MedTrace Logo

Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors

NCT07114614 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-05-27

No results posted yet for this study

Summary

The purpose of this research study is to investigate whether cancer survivors have higher levels of proteins called Fatty Acid Binding Proteins as well as 12 different markers of cellular senescence than people who have never had cancer. Investigators believe that these levels may be elevated in cancer survivors as a result of their cancer and the treatments they received and may put them at higher risk for chronic conditions such as high cholesterol, diabetes, high blood pressure, and obesity. This study will also compare the levels of these proteins and inflammatory markers in the blood with different aspects of cancer treatment the survivors received. Investigators are investigating if there is a correlation between levels of these proteins and markers, the type of treatment cancer survivors received, and development of metabolic conditions.

Conditions

  • Marker; Structural

Interventions

OTHER

Specimen #1

Specimen 1 will be collected in a 10 ml SST (serum separator tube).

OTHER

Specimen #2

Specimen #2 will be collected in a 10 ml SST (serum separator tube)

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07114614 on ClinicalTrials.gov